
New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 diabetes compared to other diabetes medications.
GLP-1 medications such as Ozempic and Wegovy have transformed treatment for type 2 diabetes and obesity but new research suggests doctors may need to pay closer attention to bone health, especially i… [+5083 chars]









